Taken together, these findings not only enlighten the prominence of TET2-MC1R-YAP axis in HCC growth and sensitivity to sorafenib, but also identify its clinical relevance for prognosis of HCC. This evidence concerns the gene MC1R and hepatocellular carcinoma.